RNAZ
USDTransCode Therapeutics Inc. Common Stock
$9.500-0.410 (-4.137%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$9.910
High
$10.450
Low
$9.500
Volume
0.01M
Company Fundamentals
Market Cap
8.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.14M
Exchange
NCM
Currency
USD
52-Week Range
Low $6.15Current $9.500High $494.34
Related News
PR Newswire
TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) announces completion of Phase 1a clinical trial with TTX-MC138, an investigational inhibitor of...
View more
PR Newswire
TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) ("TransCode or the "Company") announced today that it entered into a definitive agreement to acquire...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.